JOIN THE BNMS             


Twitter @BNMSnews

Press Office

2012 President's Award - Professor Mike O'Doherty

At this year's Annual Spring Meeting,  Professor Mike O'Doherty was awarded the President's Award

This is a token gift of the President to medics who have made an exceptional contribution to nuclear medicine.

pdf Citation

Norman Veall Medal Awarded to Professor Glen Blake

Glenn_BrianProfessor Glen Blake was awarded the Norman Veall Medal by Dr Brian Neilly,  BNMS President, at the BNMS Autumn Meeting conference dinner. 

The medal is awarded to clinical scientists who have made an outstanding contribution to the science and/or practice of nuclear medicine in the United Kingdom.

The dinner was held in the dining hall of Exeter College, University of Oxford.

pdf Citation

Dr Brian Neilly becomes President

Dr Brian Neilly from Glasgow Royal Infirmary takes over as President from Prof Alan Perkins, Nottingham University Hospitals, (President from 2010 to 2012) at the closing ceremony of the BNMS Annual Spring Meeting in Harrogate on Wednesday 2nd May 2012.

Professor Alan Perkins Awarded Honorary Fellowship of the Royal College of Physicians

BNMS032In the traditional ceremony at the Royal College of Physicians in London, Professor Alan Perkins was awarded Honorary Fellowship.  This is an award made after careful consideration and scrutiny in recognition of exceptional services to the science and practice of medicine.

Professor Alan Perkins is a distinguished clinical scientist and the first non medical president of the British Nuclear Medicine Society (BNMS).  The rules of the BNMS to permit this option were amended 10 years ago but Professor Perkins was the first person who the society appointed in this role.

FDA issues radiation alert after CT brain perfusion overexposure

The U.S. Food and Drug Administration (FDA) is investigating cases of radiation overexposure during CT brain perfusion scans conducted to aid the diagnosis and treatment of stroke. The agency said that at one particular facility, patients received radiation doses that were eight times the expected level.

By Brian Casey - staff writer
October 8, 2009

Read more:

HPA Press Release-Radiation Incident Victims

Pioneering Technology will detect DNA damage to radiation incident victims.

September 16 2009 - The Health Protection Agency.

For years scientists have struggled to find quick ways of assessing the extent of radiation damage, at a cellular level, in those involved in radiological and nuclear incidents. Because of this bottleneck choosing the right treatment for people caught up in such incidents, but who are not suffering visible medical effects, can be slow.

Read full press releasedoc.

ARSAC Newsletter May '09

The latest edition of the ARSAC Newsletter has been issued on the ARSAC website
Follow this link to the website.